Header Logo

Connection

David Bennett to Neuropsychological Tests

Back to Details
This is a "connection" page, showing publications David Bennett has written about Neuropsychological Tests.
David Bennett
Connection Strength
12.271
Neuropsychological Tests
  1. Latent Cognitive Class at Enrollment Predicts Future Cognitive Trajectories of Decline in a Community Sample of Older Adults. J Alzheimers Dis. 2021; 83(2):641-652.
    View in: PubMed
    Score: 0.536
  2. Cognitive function is associated with risk aversion in community-based older persons. BMC Geriatr. 2011 Sep 11; 11:53.
    View in: PubMed
    Score: 0.281
  3. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 Jun 27; 66(12):1837-44.
    View in: PubMed
    Score: 0.196
  4. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia. J Alzheimers Dis. 2023; 96(2):563-578.
    View in: PubMed
    Score: 0.154
  5. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment. JAMA Neurol. 2022 12 01; 79(12):1277-1286.
    View in: PubMed
    Score: 0.153
  6. Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
    View in: PubMed
    Score: 0.151
  7. Reducing Your Risk of Alzheimer's Dementia: Building a Better Brain as We Age. Arch Clin Neuropsychol. 2021 Oct 13; 36(7):1257-1265.
    View in: PubMed
    Score: 0.141
  8. Improving Detection of Amnestic Mild Cognitive Impairment with Sex-Specific Cognitive Norms. J Alzheimers Dis. 2021; 84(4):1763-1770.
    View in: PubMed
    Score: 0.134
  9. Diagnosis and Management of Dementia: Review. JAMA. 2019 10 22; 322(16):1589-1599.
    View in: PubMed
    Score: 0.123
  10. Genetic risk for Alzheimer's dementia predicts motor deficits through multi-omic systems in older adults. Transl Psychiatry. 2019 10 03; 9(1):241.
    View in: PubMed
    Score: 0.123
  11. Neuropsychological latent classes at enrollment and postmortem neuropathology. Alzheimers Dement. 2019 09; 15(9):1195-1207.
    View in: PubMed
    Score: 0.122
  12. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.121
  13. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment: A Prospective Cohort Study. Ann Intern Med. 2019 05 21; 170(10):702-709.
    View in: PubMed
    Score: 0.119
  14. Education and cognitive reserve in old age. Neurology. 2019 03 05; 92(10):e1041-e1050.
    View in: PubMed
    Score: 0.117
  15. Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project. J Alzheimers Dis. 2019; 67(1):125-135.
    View in: PubMed
    Score: 0.117
  16. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.113
  17. Associations of APOE e4 With Health and Financial Literacy Among Community-Based Older Adults Without Dementia. J Gerontol B Psychol Sci Soc Sci. 2018 06 14; 73(5):778-786.
    View in: PubMed
    Score: 0.112
  18. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018 04; 83(4):718-729.
    View in: PubMed
    Score: 0.111
  19. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.109
  20. Are latent variable models preferable to composite score approaches when assessing risk factors of change? Evaluation of type-I error and statistical power in longitudinal cognitive studies. Stat Methods Med Res. 2019 07; 28(7):1942-1957.
    View in: PubMed
    Score: 0.108
  21. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
    View in: PubMed
    Score: 0.105
  22. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
    View in: PubMed
    Score: 0.103
  23. TOMM40'523 variant and cognitive decline in older persons with APOE e3/3 genotype. Neurology. 2017 Feb 14; 88(7):661-668.
    View in: PubMed
    Score: 0.102
  24. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res. 2017 03 30; 322(Pt B):233-240.
    View in: PubMed
    Score: 0.099
  25. Cognitive activity, cognitive function, and brain diffusion characteristics in old age. Brain Imaging Behav. 2016 06; 10(2):455-63.
    View in: PubMed
    Score: 0.098
  26. Grey matter correlates of susceptibility to scams in community-dwelling older adults. Brain Imaging Behav. 2016 06; 10(2):524-32.
    View in: PubMed
    Score: 0.098
  27. Financial literacy is associated with white matter integrity in old age. Neuroimage. 2016 Apr 15; 130:223-229.
    View in: PubMed
    Score: 0.096
  28. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016 Feb; 30(2):135-42.
    View in: PubMed
    Score: 0.095
  29. Mild Cognitive Impairment and Susceptibility to Scams in Old Age. J Alzheimers Dis. 2016; 49(3):845-51.
    View in: PubMed
    Score: 0.095
  30. Change in Cognitive Abilities in Older Latinos. J Int Neuropsychol Soc. 2016 Jan; 22(1):58-65.
    View in: PubMed
    Score: 0.094
  31. Discrepancies between cognition and decision making in older adults. Aging Clin Exp Res. 2016 Feb; 28(1):99-108.
    View in: PubMed
    Score: 0.091
  32. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2016 05; 221(4):2135-46.
    View in: PubMed
    Score: 0.090
  33. Conscientiousness, dementia related pathology, and trajectories of cognitive aging. Psychol Aging. 2015 Mar; 30(1):74-82.
    View in: PubMed
    Score: 0.089
  34. Negative social interactions and risk of mild cognitive impairment in old age. Neuropsychology. 2015 Jul; 29(4):561-70.
    View in: PubMed
    Score: 0.088
  35. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.088
  36. Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. Neuroepidemiology. 2014; 43(3-4):194-205.
    View in: PubMed
    Score: 0.088
  37. Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology. 2014; 43(2):131-9.
    View in: PubMed
    Score: 0.087
  38. Learning to read in older age improves cognitive performance: findings from a prospective observational study. J Am Geriatr Soc. 2014 Nov; 62(11):2218-9.
    View in: PubMed
    Score: 0.087
  39. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci. 2014 Dec; 69(12):1536-44.
    View in: PubMed
    Score: 0.086
  40. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014 Aug 19; 83(8):702-9.
    View in: PubMed
    Score: 0.086
  41. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6):666-74.
    View in: PubMed
    Score: 0.084
  42. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.082
  43. Ventromedial PFC, parahippocampal, and cerebellar connectivity are associated with temporal discounting in old age. Exp Gerontol. 2013 Dec; 48(12):1489-98.
    View in: PubMed
    Score: 0.081
  44. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct. 2014 Nov; 219(6):2029-49.
    View in: PubMed
    Score: 0.080
  45. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep; 74(3):478-89.
    View in: PubMed
    Score: 0.080
  46. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.080
  47. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.079
  48. Association of brain pathology with the progression of frailty in older adults. Neurology. 2013 May 28; 80(22):2055-61.
    View in: PubMed
    Score: 0.079
  49. Poor decision making is associated with an increased risk of mortality among community-dwelling older persons without dementia. Neuroepidemiology. 2013; 40(4):247-52.
    View in: PubMed
    Score: 0.077
  50. Neuroticism, extraversion, and motor function in community-dwelling older persons. Am J Geriatr Psychiatry. 2013 Feb; 21(2):145-54.
    View in: PubMed
    Score: 0.077
  51. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2013; 33 Suppl 1:S397-403.
    View in: PubMed
    Score: 0.077
  52. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.076
  53. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.076
  54. The natural history of cognitive decline in Alzheimer's disease. Psychol Aging. 2012 Dec; 27(4):1008-17.
    View in: PubMed
    Score: 0.075
  55. Association of cognition with temporal discounting in community based older persons. BMC Geriatr. 2012 Aug 31; 12:48.
    View in: PubMed
    Score: 0.075
  56. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2012; 39(2):73-83.
    View in: PubMed
    Score: 0.075
  57. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.074
  58. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012 Jul; 9(6):646-63.
    View in: PubMed
    Score: 0.074
  59. Alzheimer's disease can spare local metacognition despite global anosognosia: revisiting the confidence-accuracy relationship in episodic memory. Neuropsychologia. 2012 Jul; 50(9):2356-64.
    View in: PubMed
    Score: 0.074
  60. Correlates of health and financial literacy in older adults without dementia. BMC Geriatr. 2012 Jun 12; 12:30.
    View in: PubMed
    Score: 0.074
  61. Terminal decline in motor function. Psychol Aging. 2012 Dec; 27(4):998-1007.
    View in: PubMed
    Score: 0.074
  62. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry. 2012 May; 69(5):499-505.
    View in: PubMed
    Score: 0.073
  63. Terminal dedifferentiation of cognitive abilities. Neurology. 2012 Apr 10; 78(15):1116-22.
    View in: PubMed
    Score: 0.073
  64. Influence of late-life cognitive activity on cognitive health. Neurology. 2012 Apr 10; 78(15):1123-9.
    View in: PubMed
    Score: 0.073
  65. Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc. 2011 Nov; 17(6):998-1005.
    View in: PubMed
    Score: 0.071
  66. Functional connectivity variations in mild cognitive impairment: associations with cognitive function. J Int Neuropsychol Soc. 2012 Jan; 18(1):39-48.
    View in: PubMed
    Score: 0.071
  67. Harm avoidance and risk of Alzheimer's disease. Psychosom Med. 2011 Oct; 73(8):690-6.
    View in: PubMed
    Score: 0.070
  68. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011 Jul 19; 77(3):219-26.
    View in: PubMed
    Score: 0.070
  69. Datasets for special series on cognitive reserve. J Int Neuropsychol Soc. 2011 Jul; 17(4):587-92.
    View in: PubMed
    Score: 0.069
  70. Loss of motor function in preclinical Alzheimer's disease. Expert Rev Neurother. 2011 May; 11(5):665-76.
    View in: PubMed
    Score: 0.069
  71. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.068
  72. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.068
  73. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View in: PubMed
    Score: 0.067
  74. Where vascular meets neurodegenerative disease. Stroke. 2010 Oct; 41(10 Suppl):S144-6.
    View in: PubMed
    Score: 0.066
  75. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.066
  76. False recollection of emotional pictures in Alzheimer's disease. Neuropsychologia. 2010 Oct; 48(12):3614-8.
    View in: PubMed
    Score: 0.065
  77. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010; 34(1):43-9.
    View in: PubMed
    Score: 0.062
  78. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.062
  79. A battery of tests for assessing cognitive function in older Latino persons. Alzheimer Dis Assoc Disord. 2009 Oct-Dec; 23(4):384-8.
    View in: PubMed
    Score: 0.061
  80. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009 Sep 22; 73(12):920-7.
    View in: PubMed
    Score: 0.061
  81. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.060
  82. Repetition priming and change in functional ability in older persons without dementia. Neuropsychology. 2009 Jan; 23(1):98-104.
    View in: PubMed
    Score: 0.058
  83. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009; 18(3):691-701.
    View in: PubMed
    Score: 0.058
  84. Relation of hemoglobin to level of cognitive function in older persons. Neuroepidemiology. 2009; 32(1):40-6.
    View in: PubMed
    Score: 0.058
  85. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.056
  86. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems. Neurology. 2008 Apr 22; 70(17):1534-42.
    View in: PubMed
    Score: 0.055
  87. Mild Parkinsonian signs: An overview of an emerging concept. Mov Disord. 2007 Sep 15; 22(12):1681-8.
    View in: PubMed
    Score: 0.053
  88. Visuoperceptual repetition priming and progression of parkinsonian signs in aging. Neurobiol Aging. 2009 Mar; 30(3):441-9.
    View in: PubMed
    Score: 0.053
  89. Lower extremity motor function and disability in mild cognitive impairment. Exp Aging Res. 2007 Jul-Sep; 33(3):355-71.
    View in: PubMed
    Score: 0.053
  90. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.053
  91. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007 Jul; 64(7):802-8.
    View in: PubMed
    Score: 0.053
  92. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007 Nov 13; 69(20):1911-20.
    View in: PubMed
    Score: 0.053
  93. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007 Feb; 64(2):234-40.
    View in: PubMed
    Score: 0.051
  94. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006 Dec; 63(12):1763-9.
    View in: PubMed
    Score: 0.050
  95. Cognitive decline in old age: separating retest effects from the effects of growing older. Psychol Aging. 2006 Dec; 21(4):774-89.
    View in: PubMed
    Score: 0.050
  96. Memory complaints are related to Alzheimer disease pathology in older persons. Neurology. 2006 Nov 14; 67(9):1581-5.
    View in: PubMed
    Score: 0.050
  97. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.050
  98. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology. 2006; 27(3):143-53.
    View in: PubMed
    Score: 0.050
  99. The relation of lifetime cognitive activity and lifetime access to resources to late-life cognitive function in older African Americans. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006 Sep-Dec; 13(3-4):516-28.
    View in: PubMed
    Score: 0.050
  100. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006 Aug 08; 67(3):441-5.
    View in: PubMed
    Score: 0.049
  101. Parkinsonian signs in subjects with mild cognitive impairment. Neurology. 2005 Dec 27; 65(12):1901-6.
    View in: PubMed
    Score: 0.047
  102. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov; 76(11):1479-84.
    View in: PubMed
    Score: 0.047
  103. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.047
  104. Parkinsonian signs and cognitive function in old age. J Int Neuropsychol Soc. 2005 Sep; 11(5):591-7.
    View in: PubMed
    Score: 0.046
  105. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005; 25(4):163-75.
    View in: PubMed
    Score: 0.046
  106. Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc. 2005 Jul; 11(4):400-7.
    View in: PubMed
    Score: 0.046
  107. Implicit memory and Alzheimer's disease neuropathology. Brain. 2005 Sep; 128(Pt 9):2006-15.
    View in: PubMed
    Score: 0.046
  108. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.046
  109. Mild cognitive impairment: is it Alzheimer's disease or not? J Alzheimers Dis. 2005 Jun; 7(3):241-5; discussion 255-62.
    View in: PubMed
    Score: 0.046
  110. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005 Mar 08; 64(5):834-41.
    View in: PubMed
    Score: 0.045
  111. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb; 11(1):3-7.
    View in: PubMed
    Score: 0.044
  112. Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex. J Neural Transm (Vienna). 2005 Aug; 112(8):1049-56.
    View in: PubMed
    Score: 0.044
  113. A longitudinal study of implicit and explicit memory in old persons. Psychol Aging. 2004 Dec; 19(4):617-25.
    View in: PubMed
    Score: 0.044
  114. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004 May; 61(5):661-6.
    View in: PubMed
    Score: 0.042
  115. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004 Apr 13; 62(7):1148-55.
    View in: PubMed
    Score: 0.042
  116. Cerebral infarctions and the relationship of depression symptoms to level of cognitive functioning in older persons. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):211-9.
    View in: PubMed
    Score: 0.042
  117. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004 Mar; 61(3):378-84.
    View in: PubMed
    Score: 0.042
  118. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003 Oct 28; 61(8):1102-7.
    View in: PubMed
    Score: 0.041
  119. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.041
  120. Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsychol. 2003 Aug; 25(5):634-42.
    View in: PubMed
    Score: 0.040
  121. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003 Jun 24; 60(12):1909-15.
    View in: PubMed
    Score: 0.040
  122. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003 Apr 08; 60(7):1082-8.
    View in: PubMed
    Score: 0.039
  123. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003 Jan 28; 60(2):246-52.
    View in: PubMed
    Score: 0.039
  124. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry. 2002 Dec; 73(6):672-7.
    View in: PubMed
    Score: 0.038
  125. Cognitive domain harmonization and cocalibration in studies of older adults. Neuropsychology. 2023 May; 37(4):409-423.
    View in: PubMed
    Score: 0.037
  126. Caffeine Consumption and Dementia: Are Lewy Bodies the Link? Ann Neurol. 2022 06; 91(6):834-846.
    View in: PubMed
    Score: 0.037
  127. Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology. 2022 05 17; 98(20):e2036-e2045.
    View in: PubMed
    Score: 0.036
  128. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002 Feb 13; 287(6):742-8.
    View in: PubMed
    Score: 0.036
  129. Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies. Alzheimers Dement. 2022 11; 18(11):2252-2261.
    View in: PubMed
    Score: 0.036
  130. Pulmonary function is associated with cognitive decline and structural brain differences. Alzheimers Dement. 2022 07; 18(7):1335-1344.
    View in: PubMed
    Score: 0.035
  131. Physical activity, brain tissue microstructure, and cognition in older adults. PLoS One. 2021; 16(7):e0253484.
    View in: PubMed
    Score: 0.035
  132. Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021 07; 69(7):1826-1835.
    View in: PubMed
    Score: 0.034
  133. Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations. Eur J Neurol. 2021 06; 28(6):1859-1867.
    View in: PubMed
    Score: 0.034
  134. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
    View in: PubMed
    Score: 0.034
  135. Limbic-predominant Age-related TDP-43 Encephalopathy and Distinct Longitudinal Profiles of Domain-specific Literacy. Alzheimer Dis Assoc Disord. 2020 Oct-Dec; 34(4):299-305.
    View in: PubMed
    Score: 0.033
  136. Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep. 2020 08 20; 10(1):14059.
    View in: PubMed
    Score: 0.033
  137. Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults. Stroke. 2020 09; 51(9):2825-2833.
    View in: PubMed
    Score: 0.033
  138. Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents. Neurology. 2020 10 13; 95(15):e2056-e2064.
    View in: PubMed
    Score: 0.033
  139. Association of lifespan cognitive reserve indicator with the risk of mild cognitive impairment and its progression to dementia. Alzheimers Dement. 2020 06; 16(6):873-882.
    View in: PubMed
    Score: 0.032
  140. Normative Cognitive Decline in Old Age. Ann Neurol. 2020 06; 87(6):816-829.
    View in: PubMed
    Score: 0.032
  141. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.031
  142. A Latent Transition Analysis Model to Assess Change in Cognitive States over Three Occasions: Results from the Rush Memory and Aging Project. J Alzheimers Dis. 2020; 73(3):1063-1073.
    View in: PubMed
    Score: 0.031
  143. Confidence in Financial and Health Literacy and Cognitive Health in Older Persons J Alzheimers Dis. 2020; 75(4):1229-1240.
    View in: PubMed
    Score: 0.031
  144. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus. 2000; 10(2):136-42.
    View in: PubMed
    Score: 0.031
  145. Proportion of cognitive loss attributable to terminal decline. Neurology. 2020 01 07; 94(1):e42-e50.
    View in: PubMed
    Score: 0.031
  146. A Multi-study Coordinated Meta-analysis of Pulmonary Function and Cognition in Aging. J Gerontol A Biol Sci Med Sci. 2019 10 04; 74(11):1793-1804.
    View in: PubMed
    Score: 0.031
  147. Interaction between the progression of Alzheimer's disease and fractal degradation. Neurobiol Aging. 2019 11; 83:21-30.
    View in: PubMed
    Score: 0.031
  148. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.030
  149. Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study. Alzheimers Dement. 2019 07; 15(7):870-877.
    View in: PubMed
    Score: 0.030
  150. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.029
  151. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology. 2019 02 12; 92(7):e700-e709.
    View in: PubMed
    Score: 0.029
  152. Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups. J Alzheimers Dis. 2019; 70(2):611-619.
    View in: PubMed
    Score: 0.029
  153. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.029
  154. Association of Financial Literacy With Hospitalization in Community-dwelling Older Adults. Med Care. 2018 07; 56(7):596-602.
    View in: PubMed
    Score: 0.028
  155. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018 10; 70:10-17.
    View in: PubMed
    Score: 0.028
  156. Fractal regulation and incident Alzheimer's disease in elderly individuals. Alzheimers Dement. 2018 09; 14(9):1114-1125.
    View in: PubMed
    Score: 0.028
  157. Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
    View in: PubMed
    Score: 0.028
  158. Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci. 2018 01 16; 73(2):198-203.
    View in: PubMed
    Score: 0.027
  159. Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia. Epidemiology. 2018 01; 29(1):151-159.
    View in: PubMed
    Score: 0.027
  160. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. J Alzheimers Dis. 2018; 62(2):855-865.
    View in: PubMed
    Score: 0.027
  161. Sensory integration deficits support a dimensional view of psychosis and are not limited to schizophrenia. Transl Psychiatry. 2017 05 09; 7(5):e1118.
    View in: PubMed
    Score: 0.026
  162. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. J Neuropathol Exp Neurol. 2017 Feb 01; 76(2):70-88.
    View in: PubMed
    Score: 0.026
  163. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology. 2017 Feb 14; 88(7):653-660.
    View in: PubMed
    Score: 0.025
  164. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment. Acta Neuropathol Commun. 2016 12 08; 4(1):127.
    View in: PubMed
    Score: 0.025
  165. Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease. J Alzheimers Dis. 2016 06 18; 53(3):921-32.
    View in: PubMed
    Score: 0.024
  166. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.024
  167. APOE e4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline. Neurology. 2016 05 31; 86(22):2063-70.
    View in: PubMed
    Score: 0.024
  168. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry. 2017 02; 22(2):287-295.
    View in: PubMed
    Score: 0.024
  169. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.024
  170. Examination of the Factor Structure of a Global Cognitive Function Battery across Race and Time. J Int Neuropsychol Soc. 2016 Jan; 22(1):66-75.
    View in: PubMed
    Score: 0.023
  171. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.023
  172. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
    View in: PubMed
    Score: 0.023
  173. GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol Psychiatry. 2016 Feb; 21(2):189-197.
    View in: PubMed
    Score: 0.023
  174. Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology. 2015 Mar 31; 84(13):1294-300.
    View in: PubMed
    Score: 0.022
  175. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). Mol Psychiatry. 2015 Feb; 20(2):183-92.
    View in: PubMed
    Score: 0.022
  176. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology. 2014 Aug 19; 83(8):718-26.
    View in: PubMed
    Score: 0.021
  177. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013 Nov; 70(11):1418-24.
    View in: PubMed
    Score: 0.020
  178. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.020
  179. Very low levels of education and cognitive reserve: a clinicopathologic study. Neurology. 2013 Aug 13; 81(7):650-7.
    View in: PubMed
    Score: 0.020
  180. Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct; 162B(7):770-8.
    View in: PubMed
    Score: 0.020
  181. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):45-52.
    View in: PubMed
    Score: 0.020
  182. AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol. 2013; 35(1):24-34.
    View in: PubMed
    Score: 0.019
  183. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.019
  184. Association between cognitive activity and cognitive function in older Hispanics. J Int Neuropsychol Soc. 2012 Nov; 18(6):1041-51.
    View in: PubMed
    Score: 0.019
  185. Perceived discrimination and cognition in older African Americans. J Int Neuropsychol Soc. 2012 Sep; 18(5):856-65.
    View in: PubMed
    Score: 0.018
  186. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep. 2012 May 01; 35(5):633-40B.
    View in: PubMed
    Score: 0.018
  187. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology. 2012 May 08; 78(19):1464-71.
    View in: PubMed
    Score: 0.018
  188. Alzheimer's disease. Dis Mon. 1992 Jan; 38(1):1-64.
    View in: PubMed
    Score: 0.018
  189. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J Am Geriatr Soc. 2011 Aug; 59(8):1403-11.
    View in: PubMed
    Score: 0.017
  190. Cognitive activities during adulthood are more important than education in building reserve. J Int Neuropsychol Soc. 2011 Jul; 17(4):615-24.
    View in: PubMed
    Score: 0.017
  191. Explaining differences in episodic memory performance among older African Americans and Whites: the roles of factors related to cognitive reserve and test bias. J Int Neuropsychol Soc. 2011 Jul; 17(4):625-38.
    View in: PubMed
    Score: 0.017
  192. Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. Curr Alzheimer Res. 2011 Jun; 8(4):336-40.
    View in: PubMed
    Score: 0.017
  193. Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance. J Alzheimers Dis. 2011; 24(4):767-74.
    View in: PubMed
    Score: 0.017
  194. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011 Feb; 69(2):320-7.
    View in: PubMed
    Score: 0.017
  195. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View in: PubMed
    Score: 0.016
  196. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol. 2010 Apr; 67(4):475-82.
    View in: PubMed
    Score: 0.016
  197. Diabetes and cognitive systems in older black and white persons. Alzheimer Dis Assoc Disord. 2010 Jan-Mar; 24(1):37-42.
    View in: PubMed
    Score: 0.016
  198. Anti-inflammatory agents and cognitive decline in a bi-racial population. Neuroepidemiology. 2008; 30(1):45-50.
    View in: PubMed
    Score: 0.014
  199. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. J Alzheimers Dis. 2008 Feb; 13(1):53-66.
    View in: PubMed
    Score: 0.014
  200. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci. 2007 Oct 03; 27(40):10810-7.
    View in: PubMed
    Score: 0.013
  201. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007 May; 66(5):389-98.
    View in: PubMed
    Score: 0.013
  202. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S152-69.
    View in: PubMed
    Score: 0.012
  203. Change in cognitive function in Alzheimer's disease in African-American and white persons. Neuroepidemiology. 2006; 26(1):16-22.
    View in: PubMed
    Score: 0.012
  204. Socioeconomic characteristics of the community in childhood and cognition in old age. Exp Aging Res. 2005 Oct-Dec; 31(4):393-407.
    View in: PubMed
    Score: 0.012
  205. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc. 2005 Jul; 11(4):446-53.
    View in: PubMed
    Score: 0.011
  206. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.011
  207. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Arch Neurol. 2005 Mar; 62(3):425-30.
    View in: PubMed
    Score: 0.011
  208. Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology. 2005 Jan; 30(1):11-7.
    View in: PubMed
    Score: 0.011
  209. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004 Jun 08; 62(11):2021-4.
    View in: PubMed
    Score: 0.011
  210. Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly. Neurosci Lett. 2004 Apr 08; 359(1-2):104-8.
    View in: PubMed
    Score: 0.011
  211. Premorbid proneness to distress and episodic memory impairment in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004 Feb; 75(2):191-5.
    View in: PubMed
    Score: 0.010
  212. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res. 2004 Jan; 48(1):93-100.
    View in: PubMed
    Score: 0.010
  213. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
    View in: PubMed
    Score: 0.010
  214. Rate of cognitive decline and mortality in Alzheimer's disease. Neurology. 2003 Nov 25; 61(10):1356-61.
    View in: PubMed
    Score: 0.010
  215. Cognitive activity and cognitive decline in a biracial community population. Neurology. 2003 Sep 23; 61(6):812-6.
    View in: PubMed
    Score: 0.010
  216. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003 Aug; 60(8):1119-22.
    View in: PubMed
    Score: 0.010
  217. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.010
  218. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis. 2003 Feb; 5(1):39-48.
    View in: PubMed
    Score: 0.010
  219. Cognitive activity and incident AD in a population-based sample of older persons. Neurology. 2002 Dec 24; 59(12):1910-4.
    View in: PubMed
    Score: 0.010
  220. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 2002 Oct; 177(2):475-93.
    View in: PubMed
    Score: 0.009
  221. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.009
  222. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002 Feb; 51(2):145-55.
    View in: PubMed
    Score: 0.009
  223. Impaired production priming and intact identification priming in Alzheimer's disease. J Int Neuropsychol Soc. 2001 Nov; 7(7):785-94.
    View in: PubMed
    Score: 0.009
  224. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001 Oct; 58(10):1640-6.
    View in: PubMed
    Score: 0.009
  225. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2001 Aug 27; 437(3):296-307.
    View in: PubMed
    Score: 0.009
  226. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000 Nov 06; 427(1):19-30.
    View in: PubMed
    Score: 0.008
  227. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000 Aug; 69(2):172-7.
    View in: PubMed
    Score: 0.008
  228. Progression of parkinsonism and loss of cognitive function in Alzheimer disease. Arch Neurol. 2000 Jun; 57(6):855-60.
    View in: PubMed
    Score: 0.008
  229. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol. 1999 Oct; 56(10):1274-9.
    View in: PubMed
    Score: 0.008
  230. Word-stem completion priming in healthy aging and Alzheimer's disease: the effects of age, cognitive status, and encoding. Neuropsychology. 1999 Jan; 13(1):22-30.
    View in: PubMed
    Score: 0.007
  231. Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging. 1997 Sep-Oct; 18(5):463-8.
    View in: PubMed
    Score: 0.007
  232. Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation. Neurology. 1996 Sep; 47(3):727-33.
    View in: PubMed
    Score: 0.006
  233. Cessation of driving and unsafe motor vehicle operation by dementia patients. Arch Intern Med. 1991 May; 151(5):941-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.